Financhill
Sell
50

CGNX Quote, Financials, Valuation and Earnings

Last price:
$36.69
Seasonality move :
13.6%
Day range:
$36.25 - $36.76
52-week range:
$22.67 - $49.76
Dividend yield:
0.89%
P/E ratio:
56.53x
P/S ratio:
6.41x
P/B ratio:
4.12x
Volume:
400.4K
Avg. volume:
1.8M
1-year change:
-0.25%
Market cap:
$6.1B
Revenue:
$914.5M
EPS (TTM):
$0.65

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CGNX
Cognex Corp.
$261.9M $0.29 4% 34.29% $48.65
FCUV
Focus Universal, Inc.
-- -- -- -- --
KEYS
Keysight Technologies, Inc.
$1.4B $1.83 18.67% 105.35% $219.77
MLAB
Mesa Laboratories, Inc.
$60.7M $1.56 0.63% 148.96% $99.00
QRVO
Qorvo, Inc.
$1B $2.11 7.38% 329.38% $101.78
SOTK
Sono-Tek Corp.
$5.2M $0.02 1.13% 14.94% $7.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CGNX
Cognex Corp.
$36.60 $48.65 $6.1B 56.53x $0.09 0.89% 6.41x
FCUV
Focus Universal, Inc.
$1.40 -- $11.5M -- $0.00 0% 26.63x
KEYS
Keysight Technologies, Inc.
$205.33 $219.77 $35.3B 42.04x $0.00 0% 6.62x
MLAB
Mesa Laboratories, Inc.
$80.67 $99.00 $445.5M -- $0.16 0.79% 1.81x
QRVO
Qorvo, Inc.
$86.25 $101.78 $8B 37.25x $0.00 0% 2.22x
SOTK
Sono-Tek Corp.
$4.01 $7.75 $63M 41.81x $0.00 0% 3.07x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CGNX
Cognex Corp.
5.03% 2.376 1.04% 2.79x
FCUV
Focus Universal, Inc.
10.5% -0.207 0.09% 1.05x
KEYS
Keysight Technologies, Inc.
32.08% 1.500 8.87% 1.53x
MLAB
Mesa Laboratories, Inc.
50.03% -0.464 48.38% 1.29x
QRVO
Qorvo, Inc.
30.62% 1.275 18.37% 2.05x
SOTK
Sono-Tek Corp.
-- 0.871 -- 3.36x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CGNX
Cognex Corp.
$187.3M $57.8M 6.96% 7.32% 20.86% $86M
FCUV
Focus Universal, Inc.
-$7.9K -$1.2M -245.73% -254.53% -4112.89% -$1.1M
KEYS
Keysight Technologies, Inc.
$876M $186M 10.95% 15.9% 13.11% $187M
MLAB
Mesa Laboratories, Inc.
$33M $4.7M -0.43% -0.95% 7.78% $7.1M
QRVO
Qorvo, Inc.
$500.1M $187.5M 4.3% 6.36% 17.72% $42.2M
SOTK
Sono-Tek Corp.
$2.5M $421.2K 8.47% 8.47% 8.16% -$237.3K

Cognex Corp. vs. Competitors

  • Which has Higher Returns CGNX or FCUV?

    Focus Universal, Inc. has a net margin of 6.38% compared to Cognex Corp.'s net margin of -4064.11%. Cognex Corp.'s return on equity of 7.32% beat Focus Universal, Inc.'s return on equity of -254.53%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex Corp.
    67.64% $0.10 $1.6B
    FCUV
    Focus Universal, Inc.
    -27.53% -$0.16 $195.3K
  • What do Analysts Say About CGNX or FCUV?

    Cognex Corp. has a consensus price target of $48.65, signalling upside risk potential of 32.92%. On the other hand Focus Universal, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cognex Corp. has higher upside potential than Focus Universal, Inc., analysts believe Cognex Corp. is more attractive than Focus Universal, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex Corp.
    10 6 0
    FCUV
    Focus Universal, Inc.
    0 0 0
  • Is CGNX or FCUV More Risky?

    Cognex Corp. has a beta of 1.530, which suggesting that the stock is 52.973% more volatile than S&P 500. In comparison Focus Universal, Inc. has a beta of 0.283, suggesting its less volatile than the S&P 500 by 71.657%.

  • Which is a Better Dividend Stock CGNX or FCUV?

    Cognex Corp. has a quarterly dividend of $0.09 per share corresponding to a yield of 0.89%. Focus Universal, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex Corp. pays 49.59% of its earnings as a dividend. Focus Universal, Inc. pays out -- of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or FCUV?

    Cognex Corp. quarterly revenues are $276.9M, which are larger than Focus Universal, Inc. quarterly revenues of $28.7K. Cognex Corp.'s net income of $17.7M is higher than Focus Universal, Inc.'s net income of -$1.2M. Notably, Cognex Corp.'s price-to-earnings ratio is 56.53x while Focus Universal, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex Corp. is 6.41x versus 26.63x for Focus Universal, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex Corp.
    6.41x 56.53x $276.9M $17.7M
    FCUV
    Focus Universal, Inc.
    26.63x -- $28.7K -$1.2M
  • Which has Higher Returns CGNX or KEYS?

    Keysight Technologies, Inc. has a net margin of 6.38% compared to Cognex Corp.'s net margin of 17.76%. Cognex Corp.'s return on equity of 7.32% beat Keysight Technologies, Inc.'s return on equity of 15.9%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex Corp.
    67.64% $0.10 $1.6B
    KEYS
    Keysight Technologies, Inc.
    61.73% $1.32 $8.7B
  • What do Analysts Say About CGNX or KEYS?

    Cognex Corp. has a consensus price target of $48.65, signalling upside risk potential of 32.92%. On the other hand Keysight Technologies, Inc. has an analysts' consensus of $219.77 which suggests that it could grow by 7.03%. Given that Cognex Corp. has higher upside potential than Keysight Technologies, Inc., analysts believe Cognex Corp. is more attractive than Keysight Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex Corp.
    10 6 0
    KEYS
    Keysight Technologies, Inc.
    7 4 0
  • Is CGNX or KEYS More Risky?

    Cognex Corp. has a beta of 1.530, which suggesting that the stock is 52.973% more volatile than S&P 500. In comparison Keysight Technologies, Inc. has a beta of 1.194, suggesting its more volatile than the S&P 500 by 19.432%.

  • Which is a Better Dividend Stock CGNX or KEYS?

    Cognex Corp. has a quarterly dividend of $0.09 per share corresponding to a yield of 0.89%. Keysight Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex Corp. pays 49.59% of its earnings as a dividend. Keysight Technologies, Inc. pays out -- of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or KEYS?

    Cognex Corp. quarterly revenues are $276.9M, which are smaller than Keysight Technologies, Inc. quarterly revenues of $1.4B. Cognex Corp.'s net income of $17.7M is lower than Keysight Technologies, Inc.'s net income of $252M. Notably, Cognex Corp.'s price-to-earnings ratio is 56.53x while Keysight Technologies, Inc.'s PE ratio is 42.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex Corp. is 6.41x versus 6.62x for Keysight Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex Corp.
    6.41x 56.53x $276.9M $17.7M
    KEYS
    Keysight Technologies, Inc.
    6.62x 42.04x $1.4B $252M
  • Which has Higher Returns CGNX or MLAB?

    Mesa Laboratories, Inc. has a net margin of 6.38% compared to Cognex Corp.'s net margin of 4.08%. Cognex Corp.'s return on equity of 7.32% beat Mesa Laboratories, Inc.'s return on equity of -0.95%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex Corp.
    67.64% $0.10 $1.6B
    MLAB
    Mesa Laboratories, Inc.
    54.3% $0.45 $357.1M
  • What do Analysts Say About CGNX or MLAB?

    Cognex Corp. has a consensus price target of $48.65, signalling upside risk potential of 32.92%. On the other hand Mesa Laboratories, Inc. has an analysts' consensus of $99.00 which suggests that it could grow by 22.72%. Given that Cognex Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Cognex Corp. is more attractive than Mesa Laboratories, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex Corp.
    10 6 0
    MLAB
    Mesa Laboratories, Inc.
    1 2 0
  • Is CGNX or MLAB More Risky?

    Cognex Corp. has a beta of 1.530, which suggesting that the stock is 52.973% more volatile than S&P 500. In comparison Mesa Laboratories, Inc. has a beta of 0.901, suggesting its less volatile than the S&P 500 by 9.911%.

  • Which is a Better Dividend Stock CGNX or MLAB?

    Cognex Corp. has a quarterly dividend of $0.09 per share corresponding to a yield of 0.89%. Mesa Laboratories, Inc. offers a yield of 0.79% to investors and pays a quarterly dividend of $0.16 per share. Cognex Corp. pays 49.59% of its earnings as a dividend. Mesa Laboratories, Inc. pays out 175.68% of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Mesa Laboratories, Inc.'s is not.

  • Which has Better Financial Ratios CGNX or MLAB?

    Cognex Corp. quarterly revenues are $276.9M, which are larger than Mesa Laboratories, Inc. quarterly revenues of $60.7M. Cognex Corp.'s net income of $17.7M is higher than Mesa Laboratories, Inc.'s net income of $2.5M. Notably, Cognex Corp.'s price-to-earnings ratio is 56.53x while Mesa Laboratories, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex Corp. is 6.41x versus 1.81x for Mesa Laboratories, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex Corp.
    6.41x 56.53x $276.9M $17.7M
    MLAB
    Mesa Laboratories, Inc.
    1.81x -- $60.7M $2.5M
  • Which has Higher Returns CGNX or QRVO?

    Qorvo, Inc. has a net margin of 6.38% compared to Cognex Corp.'s net margin of 11.3%. Cognex Corp.'s return on equity of 7.32% beat Qorvo, Inc.'s return on equity of 6.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex Corp.
    67.64% $0.10 $1.6B
    QRVO
    Qorvo, Inc.
    47.25% $1.28 $5.1B
  • What do Analysts Say About CGNX or QRVO?

    Cognex Corp. has a consensus price target of $48.65, signalling upside risk potential of 32.92%. On the other hand Qorvo, Inc. has an analysts' consensus of $101.78 which suggests that it could grow by 18%. Given that Cognex Corp. has higher upside potential than Qorvo, Inc., analysts believe Cognex Corp. is more attractive than Qorvo, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex Corp.
    10 6 0
    QRVO
    Qorvo, Inc.
    3 19 0
  • Is CGNX or QRVO More Risky?

    Cognex Corp. has a beta of 1.530, which suggesting that the stock is 52.973% more volatile than S&P 500. In comparison Qorvo, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.562%.

  • Which is a Better Dividend Stock CGNX or QRVO?

    Cognex Corp. has a quarterly dividend of $0.09 per share corresponding to a yield of 0.89%. Qorvo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex Corp. pays 49.59% of its earnings as a dividend. Qorvo, Inc. pays out -- of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or QRVO?

    Cognex Corp. quarterly revenues are $276.9M, which are smaller than Qorvo, Inc. quarterly revenues of $1.1B. Cognex Corp.'s net income of $17.7M is lower than Qorvo, Inc.'s net income of $119.6M. Notably, Cognex Corp.'s price-to-earnings ratio is 56.53x while Qorvo, Inc.'s PE ratio is 37.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex Corp. is 6.41x versus 2.22x for Qorvo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex Corp.
    6.41x 56.53x $276.9M $17.7M
    QRVO
    Qorvo, Inc.
    2.22x 37.25x $1.1B $119.6M
  • Which has Higher Returns CGNX or SOTK?

    Sono-Tek Corp. has a net margin of 6.38% compared to Cognex Corp.'s net margin of 8.21%. Cognex Corp.'s return on equity of 7.32% beat Sono-Tek Corp.'s return on equity of 8.47%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex Corp.
    67.64% $0.10 $1.6B
    SOTK
    Sono-Tek Corp.
    48.07% $0.03 $18.7M
  • What do Analysts Say About CGNX or SOTK?

    Cognex Corp. has a consensus price target of $48.65, signalling upside risk potential of 32.92%. On the other hand Sono-Tek Corp. has an analysts' consensus of $7.75 which suggests that it could grow by 93.27%. Given that Sono-Tek Corp. has higher upside potential than Cognex Corp., analysts believe Sono-Tek Corp. is more attractive than Cognex Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex Corp.
    10 6 0
    SOTK
    Sono-Tek Corp.
    1 1 0
  • Is CGNX or SOTK More Risky?

    Cognex Corp. has a beta of 1.530, which suggesting that the stock is 52.973% more volatile than S&P 500. In comparison Sono-Tek Corp. has a beta of -0.274, suggesting its less volatile than the S&P 500 by 127.432%.

  • Which is a Better Dividend Stock CGNX or SOTK?

    Cognex Corp. has a quarterly dividend of $0.09 per share corresponding to a yield of 0.89%. Sono-Tek Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex Corp. pays 49.59% of its earnings as a dividend. Sono-Tek Corp. pays out -- of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or SOTK?

    Cognex Corp. quarterly revenues are $276.9M, which are larger than Sono-Tek Corp. quarterly revenues of $5.2M. Cognex Corp.'s net income of $17.7M is higher than Sono-Tek Corp.'s net income of $423.7K. Notably, Cognex Corp.'s price-to-earnings ratio is 56.53x while Sono-Tek Corp.'s PE ratio is 41.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex Corp. is 6.41x versus 3.07x for Sono-Tek Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex Corp.
    6.41x 56.53x $276.9M $17.7M
    SOTK
    Sono-Tek Corp.
    3.07x 41.81x $5.2M $423.7K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock